99 related articles for article (PubMed ID: 26684255)
1. Serum bilirubin levels are inversely associated with PAI-1 and fibrinogen in Korean subjects.
Cho HS; Lee SW; Kim ES; Shin J; Moon SD; Han JH; Cha BY
Atherosclerosis; 2016 Jan; 244():204-10. PubMed ID: 26684255
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
[TBL] [Abstract][Full Text] [Related]
3. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
6. Inverse association between total bilirubin and metabolic syndrome in rural korean women.
Kwon KM; Kam JH; Kim MY; Kim MY; Chung CH; Kim JK; Linton JA; Eom A; Koh SB; Kang HT
J Womens Health (Larchmt); 2011 Jun; 20(6):963-9. PubMed ID: 21671781
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin.
Kim KJ; Yang WS; Kim SB; Lee SK; Park JS
Perit Dial Int; 1997; 17(2):157-61. PubMed ID: 9159836
[TBL] [Abstract][Full Text] [Related]
8. Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study.
Jung CH; Lee MJ; Kang YM; Hwang JY; Jang JE; Leem J; Park JY; Kim HK; Lee WJ
Metabolism; 2014 Jan; 63(1):87-93. PubMed ID: 24140099
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Festa A; D'Agostino R; Tracy RP; Haffner SM;
Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
11. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
Smith AM; English KM; Malkin CJ; Jones RD; Jones TH; Channer KS
Eur J Endocrinol; 2005 Feb; 152(2):285-91. PubMed ID: 15745938
[TBL] [Abstract][Full Text] [Related]
12. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
Mertens I; Verrijken A; Michiels JJ; Van der Planken M; Ruige JB; Van Gaal LF
Int J Obes (Lond); 2006 Aug; 30(8):1308-14. PubMed ID: 16389265
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum bilirubin and gamma-glutamyltransferase levels on coronary atherosclerosis assessed by multidetector computed tomography.
Cho HS; Lee SW; Kim ES; Mo EY; Shin JY; Moon SD; Han JH
Nutr Metab Cardiovasc Dis; 2015 Jul; 25(7):677-85. PubMed ID: 26026212
[TBL] [Abstract][Full Text] [Related]
14. Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study.
Djoussé L; Ellison RC; Zhang Y; Arnett DK; Sholinsky P; Borecki I
Am J Clin Nutr; 1998 Sep; 68(3):568-75. PubMed ID: 9734732
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride concentration and waist circumference influence alcohol-related plasminogen activator inhibitor-1 activity increase in black South Africans.
Pieters M; de Lange Z; Hoekstra T; Ellis SM; Kruger A
Blood Coagul Fibrinolysis; 2010 Dec; 21(8):736-43. PubMed ID: 20881480
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study.
Raiko JR; Oikonen M; Wendelin-Saarenhovi M; Siitonen N; Kähönen M; Lehtimäki T; Viikari J; Jula A; Loo BM; Huupponen R; Saarikoski L; Juonala M; Raitakari OT
Atherosclerosis; 2012 Sep; 224(1):208-12. PubMed ID: 22840426
[TBL] [Abstract][Full Text] [Related]
17. Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men.
Jae SY; Carnethon MR; Ahn ES; Heffernan KS; Choi YH; Lee MK; Fernhall B
Atherosclerosis; 2008 Mar; 197(1):415-9. PubMed ID: 17681507
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
20. PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
Mertens I; Lemieux I; Verrijken A; Després JP; Van Gaal LF
Diabetes Metab Res Rev; 2008 Feb; 24(2):141-7. PubMed ID: 17922472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
